Aug 08, 2022
|
Chimerix Reports Second Quarter 2022 Financial Results and Provides Operational Update
|
Aug 08, 2022
|
Chimerix Appoints Christopher L. Jordan as Vice President, Regulatory Affairs
|
Aug 02, 2022
|
Chimerix to Present at Wedbush PacGrow Healthcare Conference
|
Aug 01, 2022
|
Chimerix to Report Second Quarter 2022 Financial Results and Provide an Operational Update on August 8, 2022
|
Jun 24, 2022
|
Chimerix Announces TEMBEXA Procurement Agreement for Approximately $25.3 Million with Public Health Agency of Canada
|
Jun 23, 2022
|
Chimerix Announces $9.3 Million International TEMBEXA Procurement Agreement
|
Jun 01, 2022
|
Chimerix to Present at Jefferies Global Healthcare Conference
|
May 17, 2022
|
Chimerix to Present at H.C. Wainwright Global Investment Conference
|
May 16, 2022
|
Chimerix Reports First Quarter 2022 Financial Results and Provides Operational Update
|
May 16, 2022
|
Chimerix Announces Sale of TEMBEXA to Emergent BioSolutions for up to $337.5 Million plus Royalties
|